Matthew E. Korenberg, President & COO at LIGAND PHARMACEUTICALS INC (LGND), sold 37,716 shares at $105.02 ($4.0M) on 2024-08-26, disclosed to the SEC on 2024-08-26.
Open-market sale of $4.0M LGND by President & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.54 | 1,157 | $122K | 3.1% |
| 2 | $105.54 | 1,157 | $122K | 3.1% |
| 3 | $104.09 | 2,037 | $212K | 5.3% |
| 4 | $104.09 | 2,037 | $212K | 5.3% |
| 5 | $105.13 | 4,275 | $449K | 11.3% |
| 6 | $105.13 | 4,275 |
| $449K |
| 11.3% |
| 7 | $105.02 | 6,177 | $649K | 16.3% |
| 8 | $105.02 | 6,177 | $649K | 16.3% |
| 9 | $106.32 | 5,212 | $554K | 13.9% |
| 10 | $106.32 | 5,212 | $554K | 13.9% |
| Total | $105.34 avg | 37,716 | $4.0M | 100% |
| Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |
| LGND | SELL | 2018-08-29 | $9.4M | — | Filing → |